Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.

Evidence on the use of non-steroidal anti-inflammatory drugs (NSAIDs) and corticoids for rheumatoid arthritis (RA) is inconclusive and is not up to date. This systematic review assessed the effectiveness and safety of these anti-inflammatories (AI) in the treatment of RA. COCHRANE (CENTRAL), MEDLINE...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariana Del Grossi Paglia, Marcus Tolentino Silva, Luciane Cruz Lopes, Silvio Barberato-Filho, Lauren Giustti Mazzei, Flavia Casale Abe, Cristiane de Cássia Bergamaschi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0248866&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839634350048542720
author Mariana Del Grossi Paglia
Marcus Tolentino Silva
Luciane Cruz Lopes
Silvio Barberato-Filho
Lauren Giustti Mazzei
Flavia Casale Abe
Cristiane de Cássia Bergamaschi
author_facet Mariana Del Grossi Paglia
Marcus Tolentino Silva
Luciane Cruz Lopes
Silvio Barberato-Filho
Lauren Giustti Mazzei
Flavia Casale Abe
Cristiane de Cássia Bergamaschi
author_sort Mariana Del Grossi Paglia
collection DOAJ
description Evidence on the use of non-steroidal anti-inflammatory drugs (NSAIDs) and corticoids for rheumatoid arthritis (RA) is inconclusive and is not up to date. This systematic review assessed the effectiveness and safety of these anti-inflammatories (AI) in the treatment of RA. COCHRANE (CENTRAL), MEDLINE, EMBASE, CINAHL, Web of Science and Virtual Health Library were searched to identify randomized controlled trials (RCT) with adults which used AI (dose represented in mg/day) compared with placebo or active controls and was carried out up to December of 2019. Reviewers, in pairs and independently, selected studies, performed the data extraction and assessed the risk of bias. The quality of the evidence was assessed by GRADE. Network meta-analyses were performed using the Stata v.14.2. Twenty-six articles were selected (NSAIDs = 21 and corticoids = 5). Naproxen 1,000 improved physical function, reduced pain and the number of painful joints compared to placebo. Etoricoxib 90 reduced the number of painful joints compared to placebo. Naproxen 750 reduced the number of swollen joints, except for etoricoxib 90. Naproxen 1,000, etoricoxib 90 and diclofenac 150 were better than placebo regarding patient assessment. Assessment physician showed that NSAIDs were better than placebo. Meta-analyses were not performed for prednisolone and prednisone. Naproxen 1,000 was the most effective drug and celecoxib 200 showed fewer adverse events. However, the low quality of the evidence observed for the outcomes with NSAIDs, the absence of meta-analyses to assess the outcomes with corticoids, as well as the risk of bias observed, indicate that future RCT can confirm such findings.
format Article
id doaj-art-15e63e1de2f84772b7835a6f73faa14b
institution Matheson Library
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-15e63e1de2f84772b7835a6f73faa14b2025-07-10T05:32:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01164e024886610.1371/journal.pone.0248866Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.Mariana Del Grossi PagliaMarcus Tolentino SilvaLuciane Cruz LopesSilvio Barberato-FilhoLauren Giustti MazzeiFlavia Casale AbeCristiane de Cássia BergamaschiEvidence on the use of non-steroidal anti-inflammatory drugs (NSAIDs) and corticoids for rheumatoid arthritis (RA) is inconclusive and is not up to date. This systematic review assessed the effectiveness and safety of these anti-inflammatories (AI) in the treatment of RA. COCHRANE (CENTRAL), MEDLINE, EMBASE, CINAHL, Web of Science and Virtual Health Library were searched to identify randomized controlled trials (RCT) with adults which used AI (dose represented in mg/day) compared with placebo or active controls and was carried out up to December of 2019. Reviewers, in pairs and independently, selected studies, performed the data extraction and assessed the risk of bias. The quality of the evidence was assessed by GRADE. Network meta-analyses were performed using the Stata v.14.2. Twenty-six articles were selected (NSAIDs = 21 and corticoids = 5). Naproxen 1,000 improved physical function, reduced pain and the number of painful joints compared to placebo. Etoricoxib 90 reduced the number of painful joints compared to placebo. Naproxen 750 reduced the number of swollen joints, except for etoricoxib 90. Naproxen 1,000, etoricoxib 90 and diclofenac 150 were better than placebo regarding patient assessment. Assessment physician showed that NSAIDs were better than placebo. Meta-analyses were not performed for prednisolone and prednisone. Naproxen 1,000 was the most effective drug and celecoxib 200 showed fewer adverse events. However, the low quality of the evidence observed for the outcomes with NSAIDs, the absence of meta-analyses to assess the outcomes with corticoids, as well as the risk of bias observed, indicate that future RCT can confirm such findings.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0248866&type=printable
spellingShingle Mariana Del Grossi Paglia
Marcus Tolentino Silva
Luciane Cruz Lopes
Silvio Barberato-Filho
Lauren Giustti Mazzei
Flavia Casale Abe
Cristiane de Cássia Bergamaschi
Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
PLoS ONE
title Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
title_full Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
title_fullStr Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
title_full_unstemmed Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
title_short Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
title_sort use of corticoids and non steroidal anti inflammatories in the treatment of rheumatoid arthritis systematic review and network meta analysis
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0248866&type=printable
work_keys_str_mv AT marianadelgrossipaglia useofcorticoidsandnonsteroidalantiinflammatoriesinthetreatmentofrheumatoidarthritissystematicreviewandnetworkmetaanalysis
AT marcustolentinosilva useofcorticoidsandnonsteroidalantiinflammatoriesinthetreatmentofrheumatoidarthritissystematicreviewandnetworkmetaanalysis
AT lucianecruzlopes useofcorticoidsandnonsteroidalantiinflammatoriesinthetreatmentofrheumatoidarthritissystematicreviewandnetworkmetaanalysis
AT silviobarberatofilho useofcorticoidsandnonsteroidalantiinflammatoriesinthetreatmentofrheumatoidarthritissystematicreviewandnetworkmetaanalysis
AT laurengiusttimazzei useofcorticoidsandnonsteroidalantiinflammatoriesinthetreatmentofrheumatoidarthritissystematicreviewandnetworkmetaanalysis
AT flaviacasaleabe useofcorticoidsandnonsteroidalantiinflammatoriesinthetreatmentofrheumatoidarthritissystematicreviewandnetworkmetaanalysis
AT cristianedecassiabergamaschi useofcorticoidsandnonsteroidalantiinflammatoriesinthetreatmentofrheumatoidarthritissystematicreviewandnetworkmetaanalysis